Figure 1 | British Journal of Cancer

Figure 1

From: Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer

Figure 1

Immunostaining for oestrogen receptor in core needle biopsy and surgery specimens after neoadjuvant chemotherapy. (A) Staining of tumour cells in core-needle biopsy sample (CNB) staining positively for oestrogen receptor (ER). (B) Staining of tumour cells in surgical samples with ER-negative status after neoadjuvant chemotherapy (NAC). (C) Staining of tumour cells in CNB specimens with ER-negative status. (D) Staining of tumour cells in surgical samples with ER-positive status after NAC.

Back to article page